Inventor · disambiguated record
Daniel Mcgarry
Also filed as: MCGARRY DANIEL · MCGARRY DANIEL G · MCGARRY DANIEL GERARD
44 granted patents·6 pending applications·935 citations·filing 1991–2024
98Inventor score
Files withVENATORX PHARMACEUTICALS INC29AVENTIS PHARMA INC7RHONE POULENC RORER PHARMA4SANOFI AVENTIS DEUTSCHLAND3AVENTIS PHARMA GMBH2
Top patents by PatentIndex Score
50 records- 0198US9511142B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Dec 6, 2016·50 cites·19 claims
- 0296US10669290B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2019·Granted Jun 2, 2020·8 cites·18 claims
- 0396US9783555B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Oct 10, 2017·15 cites·20 claims
- 0496US9376454B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Granted Jun 28, 2016·24 cites·20 claims
- 0596US9040504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted May 26, 2015·34 cites·18 claims
- 0696US8912169B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Dec 16, 2014·34 cites·20 claims
- 0795US9828391B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·15 cites·16 claims
- 0895US9802966B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·10 cites·20 claims
- 0995US9637504B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted May 2, 2017·19 cites·18 claims
- 1095US9403850B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·25 cites·20 claims
- 1195US6800645B1Substituted azabicyclic compoundsAVENTIS PHARMA LTD·Filed 2000·Granted Oct 5, 2004·119 cites·11 claims
- 1294US10294248B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2018·Granted May 21, 2019·7 cites·20 claims
- 1394US10214547B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Feb 26, 2019·10 cites·10 claims
- 1494US9771382B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Granted Sep 26, 2017·15 cites·19 claims
- 1594US9422314B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·22 cites·21 claims
- 1693US9944658B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2014·Granted Apr 17, 2018·10 cites·19 claims
- 1793US9926336B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Mar 27, 2018·12 cites·20 claims
- 1893US6323227B1Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1999·Granted Nov 27, 2001·76 cites·61 claims
- 1992US10294247B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·20 claims
- 2092US7005440B1Therapeutic uses of tri-aryl acid derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted Feb 28, 2006·79 cites·56 claims
- 2191US11008346B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted May 18, 2021·2 cites·20 claims
- 2291US10125152B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Nov 13, 2018·8 cites·20 claims
- 2391US6635655B1Therapeutic uses of di-aryl acid derivativesAVENTIS PHARMA GMBH·Filed 2000·Granted Oct 21, 2003·61 cites·25 claims
- 2490US11091505B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2018·Granted Aug 17, 2021·4 cites·19 claims
- 2589US10889600B2Boron-containing compoundsVENATORX PHARMACEUTICALS INC·Filed 2017·Granted Jan 12, 2021·7 cites·15 claims
- 2689US6303600B1Substituted azabicyclic compoundsRHONE POULENC RORER LTD·Filed 1998·Granted Oct 16, 2001·68 cites·38 claims
- 2789US2025236632A1Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2888US11560392B2Boron-containing compoundsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted Jan 24, 2023·2 cites·1 claims
- 2988US7329675B2Substituted azabicyclic compoundsAVENTIS PHARMA LTD·Filed 2004·Granted Feb 12, 2008·27 cites·15 claims
- 3088US5571506AAromatic oligomeric compounds useful as mimics of bioactive macromoleculesRHONE POULENC RORER PHARMA·Filed 1993·Granted Nov 5, 1996·47 cites·32 claims
- 3187US11820784B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2021·Granted Nov 21, 2023·1 cites·20 claims
- 3287US7326792B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2004·Granted Feb 5, 2008·29 cites·26 claims
- 3385US7741493B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2007·Granted Jun 22, 2010·8 cites·10 claims
- 3484US12187752B2Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2023·Granted Jan 7, 2025·0 cites·15 claims
- 3583USRE40558ETherapeutic uses of di-aryl acid derivativesSANOFI AVENTIS DEUTSCHLAND·Filed 2005·Granted Oct 28, 2008·8 cites·42 claims
- 3683US2025320235A1Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereofVENATORX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3780US6034093ASubstituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compoundsRHONE POULENC RORER PHARMA·Filed 1998·Granted Mar 7, 2000·28 cites·30 claims
- 3876US7638539B21, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic diseaseAVENTIS PHARMA INC·Filed 2006·Granted Dec 29, 2009·2 cites·2 claims
- 3974US5731315ASubstituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compoundsRHONE POULENC RORER PHARMA·Filed 1996·Granted Mar 24, 1998·20 cites·44 claims
- 4073US6541505B1Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compoundsAVENTIS PHARMA INC·Filed 2000·Granted Apr 1, 2003·7 cites·35 claims
- 4170US11414435B2Beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 4266US7872032B21, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereofAVENTIS PARMACEUTICALS INC·Filed 2009·Granted Jan 18, 2011·1 cites·4 claims
- 4365US6599918B2Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyransAVENTIS PHARMA INC·Filed 2002·Granted Jul 29, 2003·3 cites·30 claims
- 4458US7709509B2Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonistsSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Granted May 4, 2010·0 cites·32 claims
- 4557US5216015ACompounds having hypocholesterolemic propertiesRHONE POULENC RORER PHARMA·Filed 1991·Granted Jun 1, 1993·12 cites·19 claims
- 4655US2017145037A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4751US2015361108A1Orally bioavailable beta-lactamase inhibitorsVENATORX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4851US2007179191A1Oxadiazolones and derivatives thereof as ppar delta agonistsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 4948US2003153604A1Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compoundsAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 5045US7576109B21,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereofAVENTIS PHARMA INC·Filed 2006·Granted Aug 18, 2009·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Daniel Mcgarry files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →